After bin Laden, al Qaida will live on.

The week's news at a glance.

Afghanistan

Syed Saleem ShahzadAsia Times (China)Al Qaida’s torch is being passed, said Syed Saleem Shahzad in Hong Kong’s Asia Times. According to a source close to the Islamist group’s leadership, Osama bin Laden has been sick for many months. His kidney disease has grown worse, and the Saudi terrorist is now virtually bedridden, unable to stray from his dialysis machine. Two weeks ago, he asked his coterie to pray for him. Still, that doesn’t mean al Qaida is on the ropes. The No. 2 man, Ayman al-Zawahri, is “very active in Afghanistan and controlling affairs,” says the source, the son of a top Uzbek Islamist. And while bin Laden exhausted his funds long ago, the group he founded is attracting cash from other sources. Uzbek militant Tahir Yuldeshev, an al Qaida operative based in South Waziristan, Pakistan, has already received money from private donors in Turkey and Saudi Arabia. Yuldeshev says he has such steady funding that he was able to reject a Russian offer of arms and money. The Russians wanted him to promise to keep the jihad limited to Afghanistan and not bring it to the former Soviet republics of Central Asia—a promise al Qaida was not willing to give. For now, though, the source says, Afghanistan remains the focus. Al Qaida believes it is there that “Muslim armies will finally regroup and go to liberate” Muslim lands.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us